Merck MRK
NYSE MRK
$145.57 +3.17 (+2.23%)
At close: Oct 9, 2026 · 4:00 PM EDT

Merck (MRK) Liabilities from Discontinued Operations (2020)

Updated

Merck (MRK) recorded Liabilities from Discontinued Operations of $186 million in Q4 2020.

Analysis

Merck (MRK) Liabilities from Discontinued Operations (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 186.00 Mn
API Access

Merck Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=MRK&period=max&api_key=YOUR_API_KEY